MedTrace Logo

Investigating Event-Related Potentials and Eye-Tracking Measures in Hockey Players

NCT03975023 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2021-01-27

No results posted yet for this study

Summary

Traumatic brain injury (TBI) is a health issue impacting athletes and no clinical treatment protocol, other than rest, is yet established. The efficacy of a treatment protocol relies on objective, physiological measures of brain function and ultimately a quantification of injury severity.

The present study aims to assess neurophysiological markers of auditory and visual measures of brain function using the NeuroCatch Platform and eye-tracking technology, respectively. The current gold standard of TBI evaluation, including cognitive and balance assessments, will also be captured.

Conditions

Interventions

DEVICE

NeuroCatch Platform (NCP)

The NCP plays a proprietary 6-minute auditory stimulus sequence of tones and words that elicit involuntary evoked responses in the brain. Tone stimuli elicit N100 and P300 responses, and spoken word pairs elicit N400 responses. The NCP proprietary software identifies the latency and amplitude (timing and size) of three selected ERPs. Latency and amplitude values are reported as empirical (measured) values.

Sponsors & Collaborators

  • HealthTech Connex Inc.

    collaborator INDUSTRY

  • Frederick Carrick, PhD, FACCN

    lead OTHER

Eligibility

Min Age
14 Years
Max Age
25 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-07-07
Primary Completion
2019-07-11
Completion
2020-04-16
FDA Device
Yes

Countries

  • United States

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03975023 on ClinicalTrials.gov